Milestone Pharmaceuticals Inc. (MIST) AI Dilution Summary

Cash was $170,609,000 at 2026-06-30 against estimated monthly burn of $7,571,333. The funding channel in place is an at-the-market program with Cantor Fitzgerald & Co., authorised to $100,000,000, with $0 sold to date. Dilution here is driven primarily by that $100,000,000 ATM capacity.